bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Coherus Oncology Inc. logo

    Coherus Oncology Inc.

    CHRS | NASDAQ
    Chart Builder DCF Calculator
    $1.37
    +$0.02 (+1.48%)
    At close: Sep 21, 2026, 4:00 PM ET
    $1.37
    $0 (0.00%)
    Pre-market: Sep 22, 2026, 6:55 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $211.67M
    Enterprise Value
    $144.07M
    Beta
    0.94
    Average Volume
    1.07M
    Shares Outstanding (Diluted)
    154.82M
    Shares Change YoY
    33.37%
    Institutional Ownership
    52.47%
    Exchange
    NASDAQ
    ISIN
    US19249H1032

    Price Performance

    Price Change 1M
    -3.5%
    Price Change 3M
    -6.2%
    Price Change 6M
    -22.6%
    Price Change YTD
    0.0%
    Price Change 1Y
    -13.8%
    Price Change 3Y
    -69.3%
    Price Change 5Y
    -92.3%
    1M CAGR (ann.)
    7.9%
    1Y CAGR (ann.)
    -10.5%
    5Y CAGR (ann.)
    -39.0%
    All-Time CAGR
    -17.0%

    Valuation

    PE Ratio
    -1.34
    Forward PE
    N/A
    PEG Ratio
    -0.05
    Forward PEG
    0.10
    PS Ratio
    4.16
    Forward PS
    2.10
    PB Ratio
    3.48
    P/FCF Ratio
    -0.87
    P/Adj. FCF Ratio
    -0.80
    P/OCF Ratio
    -0.87
    EV/Sales
    2.83
    EV/EBIT
    -0.95
    EV/EBITDA
    -0.96
    EV/FCF
    -0.59
    Earnings Yield
    -74.5%
    FCF Yield
    -115.2%
    Adj. FCF Yield
    -125.4%

    Financial Health

    Net Cash
    $68.06M
    Total Debt
    $37.71M
    Cash & Short-Term Investments
    $105.31M
    Total Assets
    $191.18M
    Current Ratio
    1.77
    Quick Ratio
    1.70
    Debt / Equity Ratio
    0.62
    Debt / EBITDA
    -0.25
    Debt / FCF
    -0.15
    OCF / Debt
    -6.47
    Interest Coverage
    -17.24
    Altman Z-Score
    -11.58
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    63.5%
    Operating Profit Margin
    -307.4%
    EBITDA Margin
    -291.5%
    Net Profit Margin
    -257.1%
    FCF Margin
    -478.9%
    Adj. FCF Margin
    -521.1%
    SBC / Revenue
    42.3%
    SBC Impact (per share)
    -8.8%

    Returns

    Return on Assets
    -68.5%
    Return on Equity
    -181.7%
    Return on Invested Capital
    -135.4%
    Return on Capital Employed
    -135.4%
    Return on Tangible Assets
    -89.6%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -34.6%
    Revenue CAGR 5Y
    -33.6%
    Revenue CAGR 10Y
    1.5%
    EPS CAGR 3Y
    -32.2%
    EPS CAGR 5Y
    34.2%
    EPS CAGR 10Y
    5.8%
    FCF CAGR 3Y
    -70.4%
    FCF CAGR 5Y
    -3.7%
    FCF CAGR 10Y
    -1.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    17
    EPS Growth Next 3Y
    28.1%
    Revenue Growth Next 3Y
    72.7%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$0.21
    EPS Growth Est (next Q)
    -36.4%
    Revenue Est (next Q)
    $15.98M
    Revenue Growth Est (next Q)
    38.1%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $6.02
    Price Target Upside
    339.4%

    Cash Flow

    Operating Cash Flow
    $-243.92M
    Free Cash Flow
    $-243.92M
    Adj. Free Cash Flow
    $-265.45M
    FCF Per Share
    -$1.58
    OCF Per Share
    -$1.58
    OCF/S Ratio
    -478.9%

    Income Statement

    Revenue
    $50.94M
    Gross Profit
    $32.37M
    Operating Income
    $-156.6M
    EBITDA
    $-149.32M
    Net Income
    $-130.96M
    EPS (Diluted)
    -$1.02
    Revenue / Employee
    $353.72K
    Profit / Employee
    $-909.42K
    Employees
    144

    © 2026 bestshares.com. All rights reserved.